These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 37124190)

  • 1. Fetal and neonatal outcome in severe alloimmunization managed with intrauterine transfusion: 18-year experience in a tertiary referral hospital in China.
    Pan W; Wu H; Chen J; Mo X; Wang H; Fang Q; Li Y; Huang Y
    Front Pediatr; 2023; 11():1157004. PubMed ID: 37124190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal outcomes following intrauterine transfusion for hemolytic disease of the fetus and newborn: a twenty-year service review.
    Blyth U; Larsson M; Baird A; Waring G; Athiraman N
    J Matern Fetal Neonatal Med; 2022 Dec; 35(25):10220-10225. PubMed ID: 36121063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrauterine Fetal Blood Transfusion: Descriptive study of the first four years' experience in Oman.
    Al-Riyami AZ; Al-Salmani M; Al-Hashami SN; Al-Mahrooqi S; Al-Marhoobi A; Al-Hinai S; Al-Hosni S; Panchatcharam SM; Al-Arimi ZA
    Sultan Qaboos Univ Med J; 2018 Feb; 18(1):e34-e42. PubMed ID: 29666679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Intrauterine transfusión in alloimmunization Rh in México 1987-2008].
    Ramírez-Robles LJ; Gómez-Partida G; Guevara-Rubio G; Velázquez-Gómez L
    Ginecol Obstet Mex; 2010 Sep; 78(9):469-77. PubMed ID: 21961364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999.
    van Kamp IL; Klumper FJ; Meerman RH; Oepkes D; Scherjon SA; Kanhai HH
    Acta Obstet Gynecol Scand; 2004 Aug; 83(8):731-7. PubMed ID: 15255845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perinatal Outcome of Pregnant Women with RhD Sensitization: A Five-Year Cross-Sectional Study at a Tertiary Care Hospital in Ethiopia.
    Kureba AA; Gudu W; Mersha A; Jemal E; Abdosh AA
    Int J Womens Health; 2023; 15():571-578. PubMed ID: 37077284
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal outcome of fetuses receiving intrauterine transfusion for severe hydrops complicated by Rhesus hemolytic disease.
    Altunyurt S; Okyay E; Saatli B; Canbahishov T; Demir N; Ozkan H
    Int J Gynaecol Obstet; 2012 May; 117(2):153-6. PubMed ID: 22342051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemolytic disease of the fetus and newborn: systematic literature review of the antenatal landscape.
    de Winter DP; Kaminski A; Tjoa ML; Oepkes D
    BMC Pregnancy Childbirth; 2023 Jan; 23(1):12. PubMed ID: 36611144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrauterine transfusion in 103 fetuses with severe anemia caused by parvovirus infection. A multicenter retrospective study.
    Kosian P; Hellmund A; Geipel A; Bald R; Geist OM; Böckenhoff P; Jimenez-Cruz J; Deja M; Strizek B; Berg C; Gembruch U
    Arch Gynecol Obstet; 2023 Jul; 308(1):117-125. PubMed ID: 35916962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrauterine transfusion for fetal anemia due to red blood cell alloimmunization: 14 years experience in Leuven.
    Pasman SA; Claes L; Lewi L; Van Schoubroeck D; Debeer A; Emonds M; Geuten E; De Catte L; Devlieger R
    Facts Views Vis Obgyn; 2015; 7(2):129-36. PubMed ID: 26175890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The rate of decline in fetal hemoglobin following intrauterine blood transfusion in the management of red cell alloimmunization.
    O'Riordan SL; Ryan GA; Cathcart B; Hughes H; Higgins S; Fitzgerald J; Corcoran S; Walsh J; Mahony R; Carroll S; McAuliffe FM; McParland P
    Eur J Obstet Gynecol Reprod Biol; 2022 Apr; 271():93-96. PubMed ID: 35180513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fetal middle cerebral artery Doppler to time intrauterine transfusion in red-cell alloimmunization: a randomized trial.
    Dodd JM; Andersen C; Dickinson JE; Louise J; Deussen A; Grivell RM; Voto L; Kilby MD; Windrim R; Ryan G;
    Ultrasound Obstet Gynecol; 2018 Mar; 51(3):306-312. PubMed ID: 28700818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome of fetuses with congenital parvovirus B19 infection: systematic review and meta-analysis.
    Bascietto F; Liberati M; Murgano D; Buca D; Iacovelli A; Flacco ME; Manzoli L; Familiari A; Scambia G; D'Antonio F
    Ultrasound Obstet Gynecol; 2018 Nov; 52(5):569-576. PubMed ID: 29785793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrauterine Transfusion for Rhesus Alloimmunization: A Historical Retrospective Cohort from A Single Reference Center in Brazil.
    Pares DBDS; Pacheco GHAS; Lobo GAR; Araujo Júnior E
    J Clin Med; 2024 Feb; 13(5):. PubMed ID: 38592667
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful management of severe red blood cell alloimmunization in pregnancy with a combination of therapeutic plasma exchange, intravenous immune globulin, and intrauterine transfusion.
    Nwogu LC; Moise KJ; Klein KL; Tint H; Castillo B; Bai Y
    Transfusion; 2018 Mar; 58(3):677-684. PubMed ID: 29250791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management and clinical consequences of red blood cell antibodies in pregnancy: A population-based cohort study.
    Liu S; Ajne G; Wikman A; Lindqvist C; Reilly M; Tiblad E
    Acta Obstet Gynecol Scand; 2021 Dec; 100(12):2216-2225. PubMed ID: 34476807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between obstetric history and Rh(D) alloimmunization severity.
    Lobato G; Soncini CS
    Arch Gynecol Obstet; 2008 Mar; 277(3):245-8. PubMed ID: 17763861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perinatal Outcome After Intrauterine Transfusion in Rh Isoimmunized Mothers.
    Potdar O; Narkhede HR; Satoskar PR
    J Obstet Gynaecol India; 2019 Apr; 69(2):123-128. PubMed ID: 30956465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predicting Intrauterine Transfusion Interval and Perinatal Outcomes in Alloimmunized Pregnancies: Time-to-Event Survival Analysis.
    Snelgrove JW; D'Souza R; Seaward PGR; Windrim R; Kelly EN; Ryan G
    Fetal Diagn Ther; 2019; 46(6):425-432. PubMed ID: 31195389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The near disappearance of fetal hydrops in relation to current state-of-the-art management of red cell alloimmunization.
    Zwiers C; Oepkes D; Lopriore E; Klumper FJ; de Haas M; van Kamp IL
    Prenat Diagn; 2018 Nov; 38(12):943-950. PubMed ID: 30187936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.